C. Ann Merrifield is Director at JUNIPER PHARMACEUTICALS INC (JNP). They have made 10 open-market trades across 4 companies since 2015, most recently 2022-06-10.
CIK 0001247224
10 open-market purchases totalling $293K since 2015, never a sale. Across 10 scored buys the stock is up 1.3% at ninety days, and 1.3 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 30% | 30% | 50% |
| Avg Move | -12.2% | -3.0% | +1.3% |
| Alpha | -10.4% | -2.9% | -1.3% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LYRA | BUY | 2022-06-10 | 2022-06-13 | $5.05 | $20K | +11.2% | +21.6% | +25.5% |
| LYRA | BUY | 2022-05-13 | 2022-05-17 | $4.83 | $18K | +7.7% | -4.3% | +18.0% |
| LYRA | BUY | 2021-06-17 | 2021-06-22 | $8.97 | $31K | -1.6% | -15.0% | +2.9% |
| FLXN | BUY | 2019-05-23 | 2019-05-24 | $12.64 | $101K | -11.8% | -15.3% | -13.5% |
| JNP | BUY | 2016-08-26 | 2016-08-29 | $5.63 | $11K | -1.7% | -0.7% | -2.6% |
| FLXN | BUY | 2016-06-14 | 2016-06-16 | $13.39 | $13K | +7.7% | +13.6% | +14.8% |
| JNP | BUY | 2015-12-04 | 2015-12-08 | $12.14 | $19K | -38.7% | -21.8% | -24.8% |
| FLXN | BUY | 2015-09-11 | 2015-09-14 | $23.00 | $23K | -19.2% | -4.0% | -4.0% |
| JNP | BUY | 2015-08-13 | 2015-08-17 | $9.90 | $30K | -38.7% | -5.7% | -5.7% |
| NVIV | BUY | 2015-08-12 | 2015-08-14 | $12.36 | $25K | -36.6% | +2.0% | +2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.